[Experimental therapy of alveococcosis. 3. Effect of thiabendazole, sarcoylsin acridine, levamisole and mebendazole on the development of larval cysts in albino mice].
D000818:Animals; D000923:Anticestodal Agents / Q000627:therapeutic use*; D004443:Echinococcosis / Q000188:drug therapy*; D004446:Echinococcus / Q000187:drug effects*; D007814:Larva / Q000187:drug effects; D007978:Levamisole / Q000627:therapeutic use; D008463:Mebendazole / Q000627:therapeutic use; D051379:Mice; D013827:Thiabendazole / Q000627:therapeutic use
D000923:Anticestodal Agents; D007978:Levamisole; D008463:Mebendazole; D013827:Thiabendazole
Eksperimental'naia terapiia al'veokokkoza. Soobshchenie III. Vliianie tiabendazola, sarkolizinakridina, levamizola i mebendazola na razvitie larvotsist al'veokokka u belykh mysheĭ